Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARDIOX: Hyperoxia During Cardiopulmonary Bypass
NCT02819739Phase 3Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Nov 2014
- Primary completion
- Oct 2018
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxygen in Cardiac arrhythmias and myocardial ischemia-reperfusion injury (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Disorders of heart rhythm (atrial fibrillation, tachycardia or ventricular fibrillation) at 15 days. Started Nov 2014; status: completed.
02
Drugs
oxygen
03
Conditions
Cardiac arrhythmiasmyocardial ischemia-reperfusion injury
Beyond the preview
Go deeper on NCT02819739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819739.